Breast Cancer-Derived Lung Metastases Show Increased Pyruvate Carboxylase-Dependent Anaplerosis

Stefan Christen(Rega Institute for Medical Research), Doriane Lorendeau(Rega Institute for Medical Research), Roberta Schmieder(Rega Institute for Medical Research), Dorien Broekaert(Rega Institute for Medical Research), Kristine L. Metzger(Rega Institute for Medical Research), Koen Veys(KU Leuven), Ilaria Elia(Rega Institute for Medical Research), Joerg M. Buescher(Rega Institute for Medical Research), Martin F. Orth(München Klinik), Shawn M. Davidson(Massachusetts Institute of Technology), Thomas Georg Philipp Grünewald(München Klinik), Katrien De Bock(ETH Zurich), Sarah‐Maria Fendt(VIB-KU Leuven Center for Cancer Biology)
Cell Reports
October 1, 2016
Cited by 269Open Access
Full Text

Abstract

Cellular proliferation depends on refilling the tricarboxylic acid (TCA) cycle to support biomass production (anaplerosis). The two major anaplerotic pathways in cells are pyruvate conversion to oxaloacetate via pyruvate carboxylase (PC) and glutamine conversion to α-ketoglutarate. Cancers often show an organ-specific reliance on either pathway. However, it remains unknown whether they adapt their mode of anaplerosis when metastasizing to a distant organ. We measured PC-dependent anaplerosis in breast-cancer-derived lung metastases compared to their primary cancers using in vivo 13C tracer analysis. We discovered that lung metastases have higher PC-dependent anaplerosis compared to primary breast cancers. Based on in vitro analysis and a mathematical model for the determination of compartment-specific metabolite concentrations, we found that mitochondrial pyruvate concentrations can promote PC-dependent anaplerosis via enzyme kinetics. In conclusion, we show that breast cancer cells proliferating as lung metastases activate PC-dependent anaplerosis in response to the lung microenvironment.


Related Papers

No related papers found

Powered by citation graph analysis